| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
endoglin | 0.446 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.917 | 2 | 0 | 2004 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
phenotype | 0.400 | None | 0.917 | 1 | 0 | 2008 | 2019 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
phenotype | 0.100 | None | 0.917 | 1 | 0 | 2004 | 2019 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
phenotype | 0.100 | None | 0.917 | 1 | 0 | 1996 | 2020 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.917 | 1 | 0 | 2007 | 2019 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
phenotype | 0.100 | None | 0.923 | 3 | 0 | 2007 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.925 | 2 | 0 | 1995 | 2020 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
phenotype | 0.100 | None | 0.927 | 1 | 0 | 1992 | 2019 | ||||||||
|
nestin | 0.450 | 0.808 | 1.6E-06 |
|
phenotype | 0.100 | None | 0.929 | 1 | 0 | 2005 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.932 | 3 | 0 | 2003 | 2020 | ||||||||
|
moesin | 0.534 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.933 | 2 | 0 | 1998 | 2019 | ||||||||
|
S100 calcium binding protein A6 | 0.510 | 0.808 | 0.18 |
|
phenotype | 0.100 | None | 0.933 | 1 | 0 | 1993 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.600 | None | 0.936 | 13 | 0 | 1991 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.936 | 2 | 0 | 1993 | 2019 | ||||||||
|
TIAM Rac1 associated GEF 1 | 0.579 | 0.731 | 0.96 |
|
phenotype | 0.100 | None | 0.938 | 4 | 0 | 2003 | 2019 | ||||||||
|
keratin 19 | 0.460 | 0.731 | 4.3E-03 |
|
phenotype | 0.100 | None | 0.938 | 1 | 0 | 1996 | 2019 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
phenotype | 0.400 | None | 0.940 | 10 | 0 | 1989 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.940 | 2 | 0 | 1992 | 2020 | ||||||||
|
C-C motif chemokine ligand 20 | 0.474 | 0.846 | 2.4E-04 |
|
phenotype | 0.400 | None | 0.941 | 1 | 0 | 2006 | 2019 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
phenotype | 0.100 | None | 0.941 | 1 | 0 | 2003 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.942 | 2 | 0 | 1992 | 2020 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
phenotype | 0.100 | None | 0.944 | 4 | 0 | 2004 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 0.944 | 3 | 0 | 1996 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
phenotype | 0.100 | None | 0.944 | 1 | 0 | 1995 | 2019 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
phenotype | 0.100 | None | 0.949 | 1 | 0 | 2003 | 2019 |